Werewolf Therapeutics, Inc.
HOWL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $64,131 | $137,596 | $59,171 | $325,298 |
| - Cash | $110,995 | $134,343 | $129,315 | $157,531 |
| + Debt | $37,087 | $51,923 | $14,684 | $15,661 |
| Enterprise Value | -$9,777 | $55,176 | -$55,460 | $183,428 |
| Revenue | $1,885 | $19,943 | $16,401 | $0 |
| % Growth | -90.5% | 21.6% | – | – |
| Gross Profit | $71 | $18,179 | $13,891 | $0 |
| % Margin | 3.8% | 91.2% | 84.7% | – |
| EBITDA | -$64,045 | -$32,465 | -$51,300 | -$49,871 |
| % Margin | -3,397.6% | -162.8% | -312.8% | – |
| Net Income | -$70,515 | -$37,368 | -$53,810 | -$49,983 |
| % Margin | -3,740.8% | -187.4% | -328.1% | – |
| EPS Diluted | -1.63 | -1.05 | -1.86 | -10.94 |
| % Growth | -55.2% | 43.5% | 83% | – |
| Operating Cash Flow | -$56,188 | -$32,612 | -$40,596 | -$42,876 |
| Capital Expenditures | -$254 | -$769 | -$3,611 | -$498 |
| Free Cash Flow | -$56,442 | -$33,381 | -$44,207 | -$43,374 |